ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.

Détails

ID Serval
serval:BIB_B130050026C9
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.
Périodique
Annals of oncology
Auteur⸱e⸱s
Keilholz U., Ascierto P.A., Dummer R., Robert C., Lorigan P., van Akkooi A., Arance A., Blank C.U., Chiarion Sileni V., Donia M., Faries M.B., Gaudy-Marqueste C., Gogas H., Grob J.J., Guckenberger M., Haanen J., Hayes A.J., Hoeller C., Lebbé C., Lugowska I., Mandalà M., Márquez-Rodas I., Nathan P., Neyns B., Olofsson Bagge R., Puig S., Rutkowski P., Schilling B., Sondak V.K., Tawbi H., Testori A., Michielin O.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Statut éditorial
Publié
Date de publication
11/2020
Peer-reviewed
Oui
Volume
31
Numéro
11
Pages
1435-1448
Langue
anglais
Notes
Publication types: Practice Guideline ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. The aim of the conference was to develop recommendations on topics that are not covered in detail in the current ESMO Clinical Practice Guideline and where available evidence is either limited or conflicting. The main topics identified for discussion were (i) the management of locoregional disease; (ii) targeted versus immunotherapies in the adjuvant setting; (iii) targeted versus immunotherapies for the first-line treatment of metastatic melanoma; (iv) when to stop immunotherapy or targeted therapy in the metastatic setting; and (v) systemic versus local treatment for brain metastases. The expert panel was divided into five working groups to each address questions relating to one of the five topics outlined above. Relevant scientific literature was reviewed in advance. Recommendations were developed by the working groups and then presented to the entire panel for further discussion and amendment before voting. This manuscript presents the results relating to the management of metastatic melanoma, including findings from the expert panel discussions, consensus recommendations and a summary of evidence supporting each recommendation. All participants approved the final manuscript.
Mots-clé
Consensus, Humans, Medical Oncology, Melanoma/therapy, Netherlands, consensus, immunotherapy, melanoma, metastatic, targeted therapy, treatment
Pubmed
Web of science
Open Access
Oui
Création de la notice
17/08/2020 9:56
Dernière modification de la notice
23/03/2023 6:53
Données d'usage